Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Infectious Disease|February 27, 2024
Acute kidney injury should not be neglected - optimization of quick Pitt bacteremia score for predicting mortality in critically ill patients with bloodstream infection: a retrospective cohort studyJiaqi Cai, Ming Yang, Han Deng, et al.
BMC Pharmacology & Toxicology|July 6, 2018
Polymyxin B-induced skin hyperpigmentation: a rare case report and literature reviewGuanhao Zheng, Li Cao, Zaiqian Che, et al.
Personalized Medicine|June 28, 2022
Risk of polymyxin B-induced acute kidney injury with a non adjusted dose versus adjusted dose based on renal functionGuanhao Zheng, Jiaqi Cai, Shenghui Zhou, et al.
BMC Infectious Diseases|October 24, 2019
Pneumonia due to Pandoraea Apista after evacuation of traumatic intracranial hematomas:a case report and literature reviewChuanzhong Lin, Ning Luo, Qiang Xu, et al.
Therapeutic Innovation & Regulatory Science|October 25, 2024
Hypocalcemia Event Associated with Denosumab: A Real-World Study from FDA Adverse Event Reporting System (FAERS) DatabaseSiyuan Gao, Guanhao Zheng, Zhichao He, et al.
Antimicrobial Resistance and Infection Control|April 24, 2024
Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort studyGuanhao Zheng, Jiaqi Cai, Han Deng, et al.
Current Medical Research and Opinion|February 9, 2021
Effect of high-dose intravenous vitamin C on point-of-care blood glucose level in septic patients: a retrospective, single-center, observational case seriesJuan He, Guanhao Zheng, Xian Qian, et al.
Infectious Diseases and Therapy|August 17, 2022
Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort StudyGuanhao Zheng, Jiaqi Cai, Liang Zhang, et al.
Infectious Diseases and Therapy|July 9, 2021
Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort StudyGuanhao Zheng, Jianxin Zhang, Bei Wang, et al.
Pageof 1